nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2010-14-4-96-102nefr-1251Research ArticleПРОГРАММА НЕПРЕРЫВНОГО ПОСЛЕДИПЛОМНОГО ОБРАЗОВАНИЯ ПО НЕФРОЛОГИИPROGRAM ON CONTINUOUS POSTGRADUATE EDUCATION ON NEPHROLOGYПРАКТИЧЕСКИЕ ВОПРОСЫ ПРИМЕНЕНИЯ ЦИКЛОСПОРИНА В ЛЕЧЕНИИ ГЛОМЕРУЛОПАТИЙPRACTICAL ISSUES OF CYCLOSPORINE IN THE TREATMENT OF GLOMERULOPATHYСмирновА. В.SmirnovA. V.

кафедра пропедевтики внутренних болезней,

Научно исследовательский институт нефрологии

ТрофименкоИ. И.TrofimenkoI. I.

кафедра пропедевтики внутренних болезней

197022, Санкт-Петербург, ул. Л.Толстого, д. 17, СПбГМУ им. акад. И.П.Павлова, тел. (812)-234-91-94.

it@nephrolog.ruСанкт-Петербургский государственный медицинский университет им. акад. И.П. ПавловаRussian Federation20101004201014496102Copyright © Смирнов А.В., Трофименко И.И., 20102010Смирнов А.В., Трофименко И.И.Smirnov A.V., Trofimenko I.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/1251

На основании современных представлений о механизмах действия циклоспорина изложены практические рекомендации по его применению при различных формах идиопатических гломерулопатий.

Based on current concepts of mechanisms of action of cyclosporine the practical recommendations on its application in various forms of idiopathic glomerulopathies are provided.

циклоспоринлечение гломерулопатийфокально-сегментарный гломерулосклерозболезнь минимальных изменениймембранозная нефропатияcyclosporineglomerulopathy treatmentfocal segmental glomerulosclerosisminimal change diseasemembranous nephropathyReferencesСмирнов АВ. Лечение гломерулопатий циклоспорином. Правильный подход с неверным обоснованием. Нефрология 2010; 14 (4): 9-22Смирнов АВ. Лечение гломерулопатий циклоспорином. Правильный подход с неверным обоснованием. Нефрология 2010; 14 (4): 9-22Alexopoulos E, Papagianni A, Tsamelashvili M et al. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. Nephrol Dial Transplant 2006; 21 (11): 3127-3132Alexopoulos E, Papagianni A, Tsamelashvili M et al. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. Nephrol Dial Transplant 2006; 21 (11): 3127-3132Cattran DC, Alexopoulos E, Heering P et al. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations. Kidney Int 2007; 72 (12): 1429-1447Cattran DC, Alexopoulos E, Heering P et al. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations. Kidney Int 2007; 72 (12): 1429-1447Goumenos DS, Katopodis KP, Passadakis P et al. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs. Am J Nephrol 2007; 27 (3): 226-231Goumenos DS, Katopodis KP, Passadakis P et al. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs. Am J Nephrol 2007; 27 (3): 226-231Ehrich JH, Geerlings C, Zivicnjak M et al. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated. Nephrol Dial Transplant 2007; 22 (8): 2183-2193Ehrich JH, Geerlings C, Zivicnjak M et al. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated. Nephrol Dial Transplant 2007; 22 (8): 2183-2193Goumenos DS. What have we learned from the use of cyclosporine A in the treatment of nephrotic patients with idiopathic membranous nephropathy? Expert Opin Pharmacother 2008; 9(10): 1695-1704Goumenos DS. What have we learned from the use of cyclosporine A in the treatment of nephrotic patients with idiopathic membranous nephropathy? Expert Opin Pharmacother 2008; 9(10): 1695-1704Braun N, Schmutzler F, Lange C et al. Immunosuppressive treatment for focal segmental glomerulosclerosis in adults. Cochrane Database Syst Rev 2008; 16 (3): CD003233Braun N, Schmutzler F, Lange C et al. Immunosuppressive treatment for focal segmental glomerulosclerosis in adults. Cochrane Database Syst Rev 2008; 16 (3): CD003233Захарова ЕВ, Бирюкова ЛС. Роль циклоспорина в лечении идиопатического гломерулонефрита и волчаночного нефрита. Нефрология и диализ 2010; 12(2): 126-141Захарова ЕВ, Бирюкова ЛС. Роль циклоспорина в лечении идиопатического гломерулонефрита и волчаночного нефрита. Нефрология и диализ 2010; 12(2): 126-141Haddad and Winchester’s Clinical Management of Poisoning and Drug Overdose, Shannon MW, Borron SW, Burns MJ 4th ed., 2007; Saunders,1584Haddad and Winchester’s Clinical Management of Poisoning and Drug Overdose, Shannon MW, Borron SW, Burns MJ 4th ed., 2007; Saunders,1584Masuda S, Inui K. An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients. Pharmacol Ther 2006; 112(1): 184-198Masuda S, Inui K. An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients. Pharmacol Ther 2006; 112(1): 184-198Robert N, Wong GWK, Wright JM. Effect of cyclosporine on blood pressure. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD007893Robert N, Wong GWK, Wright JM. Effect of cyclosporine on blood pressure. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD007893Kelley’s Textbook of Rheumatology, Ed. Firestein GS, Budd RC, Harris ED,et al. 8th ed., Saunders, 2064Kelley’s Textbook of Rheumatology, Ed. Firestein GS, Budd RC, Harris ED,et al. 8th ed., Saunders, 2064Chapman JR, Nankivell BJ. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain? Nephrol Dial Transplant 2006; 21(8): 2060-2063Chapman JR, Nankivell BJ. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain? Nephrol Dial Transplant 2006; 21(8): 2060-2063Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4(2): 481-508Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4(2): 481-508Ponticelli C. De novo thrombotic microangiopathy. An underrated complication of renal transplantation. Clin Nephrol 2007; 67(6): 335-340Ponticelli C. De novo thrombotic microangiopathy. An underrated complication of renal transplantation. Clin Nephrol 2007; 67(6): 335-340Yoon HE, Yang CW. Established and newly proposed mechanisms of chronic cyclosporine nephropathy. Korean J Intern Med 2009; 24(2): 81-92Yoon HE, Yang CW. Established and newly proposed mechanisms of chronic cyclosporine nephropathy. Korean J Intern Med 2009; 24(2): 81-92Cattran DC, Appel GB, Hebert LA et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int 1999; 56 (6): 2220-2226Cattran DC, Appel GB, Hebert LA et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int 1999; 56 (6): 2220-2226Ponticelli C. Membranous nephropathy. J Nephrol 2007; 20(3): 268-287Ponticelli C. Membranous nephropathy. J Nephrol 2007; 20(3): 268-287

The authors declare that there are no conflicts of interest present.